- Forums
- ASX - By Stock
- SGA
- Ann: Pre-Feasibility Study Quantifies Exceptional Returns
Ann: Pre-Feasibility Study Quantifies Exceptional Returns, page-8
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGA (ASX) to my watchlist
|
|||||
Last
11.3¢ |
Change
-0.013(10.0%) |
Mkt cap ! $17.47M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.3¢ | $65.42K | 555.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 178998 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 17350 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 178998 | 0.110 |
9 | 230261 | 0.105 |
3 | 220000 | 0.100 |
1 | 20000 | 0.099 |
1 | 25000 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 17350 | 2 |
0.120 | 44769 | 3 |
0.125 | 20768 | 2 |
0.130 | 80000 | 1 |
0.135 | 20000 | 1 |
Last trade - 12.54pm 13/08/2024 (20 minute delay) ? |
Featured News
SGA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online